The first UK research study into the medical benefits of cannabis on Multiple Scelrosis has shown there is no benefit.
However there were benefits for those at the lower end of the disability scale.
The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study was carried out by researchers from the Peninsula College of Medicine and Dentistry.
It enrolled nearly 500 people with MS from 27 centres around the UK, who were either given capsules containing the active ingredient of cannabis and some given a placebo.
Alison Smith, an MS sufferer took part in the trial:
More top news
Nigel Farage added that he was told Donald Trump was his warm-up at the rally in Mississippi.
Dr Dan Poulter suggests that increasing national insurance could be the key to the NHS's funding crisis.
The beloved British high street chain will disappear from Britain's towns on Sunday as the last stores close down.